NYSE · LFVN
Consumer Defensive · Packaged Foods
$6.26
Down-$0.03 (-0.48%)
Updated Sep 26, 2026, 7:24 PM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
LFVN closed at $6.26 after 20 trading sessions, down 1.49% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $6.29 | $6.4195 | $6.25 | $6.26 | 10.35K |
| Sep 24, 2026 | $6.20 | $6.29 | $6.11 | $6.29 | 24.42K |
| Sep 23, 2026 | $6.12 | $6.20 | $6.00 | $6.20 | 75.86K |
| Sep 22, 2026 | $6.16 | $6.32 | $6.15 | $6.22 | 38.17K |
| Sep 21, 2026 | $6.31 | $6.40 | $6.16 | $6.22 | 34.22K |
| Sep 18, 2026 | $6.31 | $6.5399 | $6.14 | $6.35 | 51.03K |
| Sep 17, 2026 | $6.295 | $6.3799 | $6.13 | $6.20 | 22.27K |
| Sep 16, 2026 | $6.30 | $6.3759 | $6.15 | $6.18 | 36.89K |
| Sep 15, 2026 | $6.25 | $6.32 | $6.1257 | $6.18 | 28.4K |
| Sep 14, 2026 | $6.09 | $6.308 | $6.09 | $6.25 | 41.09K |
| Sep 11, 2026 | $6.35 | $6.66 | $5.99 | $6.17 | 72.73K |
| Sep 10, 2026 | $6.57 | $6.58 | $6.2616 | $6.37 | 30.27K |
| Sep 9, 2026 | $6.34 | $6.69 | $6.30 | $6.51 | 67.98K |
| Sep 8, 2026 | $6.20 | $6.76 | $6.20 | $6.34 | 105.87K |
| Sep 4, 2026 | $6.11 | $6.29 | $6.11 | $6.25 | 12K |
| Sep 3, 2026 | $6.19 | $6.345 | $6.095 | $6.105 | 18.87K |
| Sep 2, 2026 | $6.15 | $6.37 | $6.11 | $6.13 | 50.59K |
| Sep 1, 2026 | $6.19 | $6.4899 | $6.10 | $6.23 | 62.66K |
| Aug 31, 2026 | $6.28 | $6.38 | $6.0246 | $6.33 | 54.54K |
| Aug 28, 2026 | $6.00 | $6.625 | $5.86 | $6.355 | 112.94K |
The latest Smart Investors Daily articles mentioning LFVN.
LFVN research
Company profile and research snapshot.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 28, 2026 | Lake Street | Hold | — |
| May 7, 2026 | Lake Street | Hold | — |
| Jan 14, 2025 | Craig-Hallum | Buy | — |
| Dec 19, 2024 | Lake Street | Buy | — |
Generated Sep 26, 2026, 5:02 PM
LifeVantage shares declined modestly by 0.48% today despite the company unveiling a comprehensive turnaround plan aimed at rebuilding its brand, margins, and growth trajectory. The muted market reaction suggests investors are taking a wait-and-see approach to management's strategic initiatives, questioning whether execution will match ambition.
Bottom line: LifeVantage's turnaround plan represents management's acknowledgment of fundamental business challenges but has failed to move the needle with the investing community, likely due to historical execution concerns. Investors should demand detailed metrics and quarterly progress updates before increasing conviction, while monitoring whether margin improvements and brand initiatives translate into sustainable revenue growth.
Yahoo · Sep 24, 2026
Lifevantage (NASDAQ:LFVN) executives outlined a turnaround plan centered on strengthening the company’s brand, improving consumer relevance and increasing operating efficiency during a Water Tower Research conference discussion. President and CEO Terrence Moorehead, who recently joined the company,
Yahoo · Sep 18, 2026
SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Terrence Moorehead, Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the upcoming WTR Virtual Insights Conference on Wednesday, September 23, 2026. The webcast of the presentation will begin at approximately 1:30 p.m. Eastern Time
Benzinga · Sep 15, 2026
Disclosed on September 14, Kristen Cunningham, Chief Sales Officer at Lifevantage (NASDAQ:LFVN), executed a substantial insider sell as per the latest SEC filing. What Happened: Cunningham's decision to sell 9,001
Yahoo · Aug 31, 2026
Revenue fell 23% as macroeconomic pressures weighed on orders and average order sizes.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning LFVN.
